Standard Biotools Inc. (LAB)
NASDAQ · Healthcare
Standard Biotools Inc. Operating Income 2009–2025
Standard Biotools Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Standard Biotools Inc. operating income for the quarter ending March 31, 2026 was -12.5 M, a 53.67% decrease year-over-year.
- Standard Biotools Inc. operating income for the twelve months ending March 31, 2026 was -98.1 M, a 29.07% decrease year-over-year.
- Standard Biotools Inc. annual operating income for 2025 was -110.2 M, a 13.52% decrease from 2024.
- Standard Biotools Inc. annual operating income for 2024 was -127.5 M, a 66.43% increase from 2023.
- Standard Biotools Inc. annual operating income for 2023 was -76.6 M, a 34.08% decrease from 2022.
- Standard Biotools Inc. annual operating income for 2022 was -116.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Standard Biotools Inc. Operating Income — FAQ
Standard Biotools Inc. (LAB) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Standard Biotools Inc.'s operating income?
Standard Biotools Inc. (LAB) reported operating income of -$110M for fiscal 2025.
Where can I see LAB's operating income history?
The chart and table above show Standard Biotools Inc.'s operating income by year and by quarter, including the growth rate.